Randomized study of the effects of Aerochamber Plus ® Flow-Vu ® on the efficacy, pharmacokinetics and safety of glycopyrronium/formoterol fumarate dihydrate metered dose inhaler in patients with chronic obstructive pulmonary disease
Author:
Funder
AstraZeneca, Cambridge, UK
Publisher
Elsevier BV
Subject
Pulmonary and Respiratory Medicine
Reference31 articles.
1. Spacer devices for metered dose inhalers;Newman;Clin. Pharmacokinet.,2004
2. Targeting drugs to the airways: the role of spacer devices;Lavorini;Expet Opin. Drug Deliv.,2009
3. In vitro comparison of the amount of salbutamol available for inhalation from different formulations used with different spacer devices;Barry;Eur. Respir. J.,1997
4. The evolution of spacers and valved holding chambers;Nikander;J. Aerosol Med. Pulm. Drug Deliv.,2014
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Physiologically Based Pharmacokinetic Modelling of Glycopyrronium in Patients With Renal Impairment;Journal of Pharmaceutical Sciences;2021-01
2. Glycopyrrolate and formoterol fumarate for the treatment of COPD;Expert Review of Respiratory Medicine;2020-10-12
3. Pharmacokinetics, pharmacodynamics and safety of a novel extrafine BDP/FF/GB combination delivered via metered-dose inhaler in healthy Chinese subjects;European Journal of Pharmaceutical Sciences;2020-03
4. Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD;Pulmonary Pharmacology & Therapeutics;2020-02
5. Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD;International Journal of Chronic Obstructive Pulmonary Disease;2020-01
Efficacy And Safety Of Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler (GFF MDI) Formulated Using Co-Suspension Delivery Technology In Chinese Patients With COPD
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3